343 related articles for article (PubMed ID: 9300223)
1. Autoantibodies to oxidized low density lipoprotein: the relationship to low density lipoprotein fatty acid composition in diabetes.
Griffin ME; McInerney D; Fraser A; Johnson AH; Collins PB; Owens D; Tomkin GH
Diabet Med; 1997 Sep; 14(9):741-7. PubMed ID: 9300223
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies against oxidized low-density lipoprotein and C-reactive protein are associated with diabetes and myocardial infarction in women.
Dotevall A; Hulthe J; Rosengren A; Wiklund O; Wilhelmsen L
Clin Sci (Lond); 2001 Nov; 101(5):523-31. PubMed ID: 11672458
[TBL] [Abstract][Full Text] [Related]
3. Presence of autoantibodies against oxidatively modified low-density lipoprotein in essential hypertension: a biochemical signature of an enhanced in vivo low-density lipoprotein oxidation.
Maggi E; Marchesi E; Ravetta V; Martignoni A; Finardi G; Bellomo G
J Hypertens; 1995 Jan; 13(1):129-38. PubMed ID: 7759843
[TBL] [Abstract][Full Text] [Related]
4. The level of autoantibodies against oxidized LDL is not associated with the presence of coronary heart disease or diabetic kidney disease in patients with non-insulin-dependent diabetes mellitus.
Leinonen JS; Rantalaiho V; Laippala P; Wirta O; Pasternack A; Alho H; Jaakkola O; Ylä-Herttuala S; Koivula T; Lehtimäki T
Free Radic Res; 1998 Aug; 29(2):137-41. PubMed ID: 9790515
[TBL] [Abstract][Full Text] [Related]
5. [Immune response against modified low-density lipoproteins in patients with non-insulin-dependent diabetes mellitus].
González M; Rojas N; Durán D; Schade A; Campos R; Milos C
Rev Med Chil; 1997 Aug; 125(8):879-85. PubMed ID: 9567390
[TBL] [Abstract][Full Text] [Related]
6. Relationships between serum levels of autoantibodies against oxidized low density lipoproteins, lipid-soluble antioxidants and apolipoprotein B in patients with coronary heart disease.
Bakalova RA; Hadzhimitova V; Ribarov S
Gen Physiol Biophys; 2000 Mar; 19(1):103-13. PubMed ID: 10930142
[TBL] [Abstract][Full Text] [Related]
7. Oxidized to non-oxidized lipoprotein ratios are associated with arteriosclerosis and the metabolic syndrome in diabetic patients.
Girona J; Manzanares JM; Marimón F; Cabré A; Heras M; Guardiola M; Ribalta J; Masana L
Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):380-7. PubMed ID: 17904830
[TBL] [Abstract][Full Text] [Related]
8. Auto antibodies against oxidized low density lipoprotein in severe preeclampsia.
Jain M; Sawhney H; Aggarwal N; Vashistha K; Majumdhar S
J Obstet Gynaecol Res; 2004 Jun; 30(3):188-92. PubMed ID: 15210040
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein.
Tsimikas S; Lau HK; Han KR; Shortal B; Miller ER; Segev A; Curtiss LK; Witztum JL; Strauss BH
Circulation; 2004 Jun; 109(25):3164-70. PubMed ID: 15184281
[TBL] [Abstract][Full Text] [Related]
10. Antibody against oxidized low-density lipoprotein predicting myocardial infarction.
Puurunen M; Mänttäri M; Manninen V; Tenkanen L; Alfthan G; Ehnholm C; Vaarala O; Aho K; Palosuo T
Arch Intern Med; 1994 Nov; 154(22):2605-9. PubMed ID: 7979858
[TBL] [Abstract][Full Text] [Related]
11. High circulating autoantibodies against human oxidized low-density lipoprotein are related to stable and lower titers to unstable clinical situation.
Santos AO; Fonseca FA; Fischer SM; Monteiro CM; Brandão SA; Póvoa RM; Bombig MT; Carvalho AC; Monteiro AM; Ramos E; Gidlund M; Figueiredo Neto AM; Izar MC
Clin Chim Acta; 2009 Aug; 406(1-2):113-8. PubMed ID: 19523463
[TBL] [Abstract][Full Text] [Related]
12. Increased levels of high-density lipoprotein cholesterol are ineffective in inhibiting the development of immune responses to oxidized low-density lipoprotein and atherosclerosis in transgenic rabbits expressing human apolipoprotein (apo) A-I with severe hypercholesterolaemia.
Boullier A; Hennuyer N; Tailleux A; Furman C; Duverger N; Caillaud JM; Castro G; Fievet C; Fruchart JC; Duriez P
Clin Sci (Lond); 2001 Mar; 100(3):343-55. PubMed ID: 11222122
[TBL] [Abstract][Full Text] [Related]
13. Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial.
Fraley AE; Schwartz GG; Olsson AG; Kinlay S; Szarek M; Rifai N; Libby P; Ganz P; Witztum JL; Tsimikas S;
J Am Coll Cardiol; 2009 Jun; 53(23):2186-96. PubMed ID: 19497447
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies to malondialdehyde-modified low-density lipoprotein in patients with angiographically confirmed coronary artery disease.
McDowell A; Young IS; Wisdom GB
J Pharm Pharmacol; 2002 Dec; 54(12):1651-7. PubMed ID: 12542895
[TBL] [Abstract][Full Text] [Related]
15. Oxidized low-density lipoprotein autoantibodies, chronic infections, and carotid atherosclerosis in a population-based study.
Mayr M; Kiechl S; Tsimikas S; Miller E; Sheldon J; Willeit J; Witztum JL; Xu Q
J Am Coll Cardiol; 2006 Jun; 47(12):2436-43. PubMed ID: 16781371
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies against malondialdehyde-modified lipoprotein(a) in antiphospholipid syndrome.
Romero FI; Atsumi T; Tinahones FJ; Gómez-Zumaquero JM; Amengual O; Khamashta MA; Hughes GR
Arthritis Rheum; 1999 Dec; 42(12):2606-11. PubMed ID: 10616007
[TBL] [Abstract][Full Text] [Related]
17. Anti-oxidized low-density lipoprotein antibodies in myeloperoxidase-positive vasculitis patients preferentially recognize hypochlorite-modified low density lipoproteins.
Slot MC; Theunissen R; van Paassen P; Damoiseaux JG; Tervaert JW;
Clin Exp Immunol; 2007 Aug; 149(2):257-64. PubMed ID: 17521320
[TBL] [Abstract][Full Text] [Related]
18. Serum antibodies to oxidized low-density lipoprotein and ceroid in chronic periaortitis.
Parums DV; Brown DL; Mitchinson MJ
Arch Pathol Lab Med; 1990 Apr; 114(4):383-7. PubMed ID: 2322097
[TBL] [Abstract][Full Text] [Related]
19. Association of the PRO12ALA polymorphism of the PPAR-gamma2 gene with oxidized low-density lipoprotein and cardiolipin autoantibodies in nondiabetic and type 2 diabetic subjects.
Niskanen L; Lindi V; Erkkilä A; Sivenius K; Luoma J; Ylä-Herttuala S; Laakso M; Uusitupa MI
Metabolism; 2003 Feb; 52(2):213-7. PubMed ID: 12601635
[TBL] [Abstract][Full Text] [Related]
20. Anti-oxidized low-density lipoprotein antibody levels are associated with the development of type 2 diabetes mellitus.
Garrido-Sánchez L; Cardona F; García-Fuentes E; Rojo-Martínez G; Gómez-Zumaquero JM; Picón MJ; Soriguer F; Tinahones FJ
Eur J Clin Invest; 2008 Sep; 38(9):615-21. PubMed ID: 18837736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]